For the treatment of Parkinson’s disease, it was reported that microRNA-30e might serve as a potential treatment for Parkinson’s disease therapeutics through the downregulation of the NLRP3 protein, ASC and procaspase-1 both in mRNA and protein levels, thus largely attenuating the NLRP3 inflammasome signaling (Li et al., 2018a). Here, NLRP3 is linked to Parkinson disease.